Araz Eivazi

1.4k citations
7 papers · 873 indexed · 1 hit paper · h-index 6
Topics
Monoclonal and Polyclonal Antibodies Research (5 papers)Glycosylation and Glycoproteins Research (3 papers)CAR-T cell therapy research (3 papers)
Partner nations
MoroccoFrance

In The Last Decade

Araz Eivazi

7 papers receiving 811 citations

Hit Papers

Engineered antibody Fc variants with enhanced effector fu...20062026201220192006100200300400500

Peers

Araz Eivazi
Comparison fields: 5 of 66
  • Radiology, Nuclear Medicine and Imaging 590
  • Molecular Biology 434
  • Immunology 377
  • Oncology 258
  • Genetics 72
Replace Jaume Pons with:
Jaume Pons United States
Taichi Kuramochi United States
Sonya James United Kingdom
Namir J. Hassan United Kingdom
Mark Tornetta United States
Suravi Raychaudhuri United States
Christian Itin Switzerland
Brad Stone United States
Mara Dottore Australia
Hok Seon Kim United States
Araz Eivazi relative to Jaume Pons United States Jaume Pons's profile →
Citations per field
00.5×3.1×
Jaume Pons · 1×
Citations per year

Countries citing papers authored by Araz Eivazi

Since Specialization
Citations

This map shows the geographic impact of Araz Eivazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Araz Eivazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Araz Eivazi more than expected).

Fields of papers citing papers by Araz Eivazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Araz Eivazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Araz Eivazi. The network helps show where Araz Eivazi may publish in the future.

Co-authorship network of co-authors of Araz Eivazi

This figure shows the co-authorship network connecting the top 25 collaborators of Araz Eivazi. A scholar is included among the top collaborators of Araz Eivazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Araz Eivazi. Araz Eivazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 11
2 5
3 1
4 49
5 89
6 128
7
Engineered antibody Fc variants with enhanced effector functionbreakdown →
590

About Araz Eivazi

Araz Eivazi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Neurology, having authored 7 papers that have together received 873 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (590 citations), Immunology (377 citations) and Oncology (258 citations). Araz Eivazi has collaborated with scholars based in Morocco and France. Frequent co-authors include Sher Karki, Greg A. Lazar, Wei Dang, Jost Vielmetter, Sean C. Yoder, Cheryl Chan, David F. Carmichael, Omid Vafa, Robert J. Hayes and Helen Chung. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026